Lipid conjugates of therapeutic peptides and protease inhibitors
US5554728A · kind A · utility
130Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 1991 |
| Grant date | Sep 10, 1996 |
| Priority date | — |
| Expiry date | Jul 23, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16222
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds wherein therapeutic peptides are covalently linked to phospholipids, glycerides or other membrane-targeting and membrane-anchoring species, and their pharmaceutically acceptable salts, together with processes for their preparation. The targeting technology is applicable to HIV protease inhibitors and a variety of other enzyme inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.